Site Search
Subscribe to our Solvency II newsletter
Please enter your e-mail address here:
Analysis & Opinion
This section provides expert analysis and clarity into the complex world of Solvency II. If you would like to view all of the publications, papers and guidance visit our publications page.
|
UK non-life insurers face an average solvency capital requirement (SCR) increase of 62% compared to the Solvency II QIS4 standard formula level, as a result of changes proposed to the implementation measures for the European regulatory standard over the past six months. This equates, on a conservative basis, to an additional €15 billion of capital that insurers across the non-life industry will have to find. The study was based on data from 49 entities with a QIS4 capitalisation of €8 billion. More |
||||
Reserving risk, risk margins and solvency: re-tuning your mindSolvency II, with its requirement for a one year view of reserving risk, raises fundamental questions about the way reserving risk is defined. The wider consequences of risk margins and solvency with simulation-based internal models are also a topic for debate. More |
||||
|
Technology plays an important part in effective risk management, but it can’t absolve people’s responsibility to use it appropriately and intelligently. While technology, and computing power in particular, has enabled mankind to achieve great things, there are limitations. Human skill and judgement cannot be eradicated from the mix. More |
||||
CEIOPS pushes on with Solvency II implementation |
||||
An insurance conundrum: The Internal Model or the Standard Formula? This paper sets out some of the respective high level benefits of using the standard formula and internal model approaches. These should at least be considered when constructing the business case either way. They may also be useful to firms considering which areas of their internal model might be simplified by using the standard formula (the partial model approach). More |
||||
Putting Solvency II into perspective for small and mid-size insurers Smaller national and regional insurers are typically among the best capitalised across Europe. Yet, even in a business climate which increasingly appears preoccupied with financial measures of health, Solvency II requires such companies to have a concerted plan of action up to implementation. Rather than regarding this as a regulatory burden, EMB believes the Directive offers great opportunities to those smaller firms willing to embrace them. More |
||||
ERM:a critical undertaking for small and medium sized enterprises All too often smaller and medium-sized insurers see increased regulation as a problem, yet Solvency II offers great opportunities to those firms willing to embrace them, says Mike Wilkinson of EMB. More |
||||
|
Andrew McGuinness of EMB summarises the main practical implications of the FSA’s recent discussion paper on Solvency II. More |
||||
New guidance for gaining maximum benefit from the Solvency II regulation This guide aims to help companies see an opportunity to introduce improvements into their business which will deliver genuine competitive advantage. More |
||||
FSA ups the pace for Solvency II By publishing its detailed Discussion Paper ‘Insurance Risk Management: The Path to Solvency II’, it’s clear the FSA is very focused on driving the UK insurance industry to meet the forthcoming Solvency II requirements. Read EMB’s analysis of this paper. More |
||||
Chief Risk Officers: a case of Quadrophenia? Many companies have recently announced the appointment of an executive level CRO. But it’s a fine balancing act to get right. Mike Wilkinson, head of risk consulting at EMB, reviews the key factors for success. More |
||||
|
Regulators around the world are converging in their assessment of insurer creditworthiness. Enterprise Risk Management (ERM) and Solvency II are on everyone’s lips. Richard Rodriguez and Dave Sommer of EMB discuss the resulting challenges and opportunities for company management. More |
||||
|
As the ICAS regime celebrates its third birthday, Mike Wilkinson of EMB discusses whether this gives UK insurers a competitive advantage for Solvency II. More |
||||
The Impact of Solvency II on Lloyd's |
||||
|
Solvency II Framework Directive Analysis |
||||
Implementing Solvency II by Understanding ERM Mike Wilkinson of EMB has written an informative briefing paper looking at Enterprise Risk Management and what UK insurers/reinsurers need to do for the implementation of Solvency II. More |
||||
Solvency II Could be Good News for Insurers and Reinsurers "Companies that take a positive view of Solvency II will gain wide-ranging business benefits", says EMB Partner, Richard Rodriguez. More |
||||
|
Companies that take a positive view of Solvency II are already seeing the commercial benefit; the rest are losing out. EMB's Andrew McGuinness reports. More |
||||
|
Solvency II will benefit reinsurers who are flexible and willing to take a broad view of their responsibilities towards customers, according to Andrzej Czernuszewicz of EMB. More |
||||
|
Solvency II makes the Key Note Address at S&P Symposium Watch Paul Sharma, chairman of the CEIOPS Internal Models Expert Group spoke at Standard & Poor’s European Insurance Symposium, discussing issues surrounding Solvency 2 and the Framework Directive. Click here to see a webcast. |
||||